Clinical Nutrition

Enter Adjacencies Neonatal Nutrition Baxter Nutrition In Oncology Subcutaneous Administration Clinical Need Drive standardized, ready-to- use PN as first line therapy for pre-term infants Timely initiation of PN in oncology improves functional and clinical outcomes, and reduces cost of cancer care Hospitalized elderly patients with poor venous access can achieve optimal nutrition with subcutaneous administration Portfolio Innovation ¿A Baxter Solution Numeta G13 Enter Development Adjacencies + Clinimix SubQ Numeta Raise awareness of benefits of Olimel MCB in Oncology patients $1.5B+ Market Opportunity Optimal Nutrition For Adjacent Patient Populations Increases Growth Opportunity | 10

View entire presentation